Assessing the chronic hepatitis B adaptive immune response by profiling specific T-cell receptor repertoire

Aliabadi, 2022, Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection, Gut, 71, 2300, 10.1136/gutjnl-2021-324646 Bertoletti, 2022, The challenges of adopting immunological biomarkers in the management of chronic HBV infection, J. Hepatol., 77, 299, 10.1016/j.jhep.2022.03.028 Bertoletti, 2016, Adaptive immunity in HBV infection, J. Hepatol., 64, S71, 10.1016/j.jhep.2016.01.026 Bertoletti, 2018, HBV infection and HCC: the 'dangerous liaisons, Gut, 67, 787, 10.1136/gutjnl-2017-315528 Bertoletti, 2022, HBV antigens quantity: duration and effect on functional cure, Gut, 71, 2149, 10.1136/gutjnl-2021-326258 Boni, 2001, Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy, Hepatology, 33, 963, 10.1053/jhep.2001.23045 Boni, 2007, Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection, J. Virol., 81, 4215, 10.1128/JVI.02844-06 Boni, 2012, Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues, Gastroenterology, 143, 963, 10.1053/j.gastro.2012.07.014 Cannons, 2001, 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy, J. Immunol., 167, 1313, 10.4049/jimmunol.167.3.1313 Chang, 2021, Profiling of T Cell repertoire in SARS-CoV-2-infected COVID-19 patients between mild disease and pneumonia, J. Clin. Immunol., 41, 1131, 10.1007/s10875-021-01045-z Chen, 2019, HBV-induced immune imbalance in the development of HCC, Front. Immunol., 10 Cheng, 2019, Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection, Sci Immunol, 4, 10.1126/sciimmunol.aau6905 Cheng, 2021, Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma, Immunity, 54, 1825, 10.1016/j.immuni.2021.06.013 Chiou, 2021, Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery, Immunity, 54, 586, 10.1016/j.immuni.2021.02.014 de Niet, 2016, Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy, J. Hepatol., 64, 539, 10.1016/j.jhep.2015.10.013 Dijkstra, 2018, Generation of tumor-reactive T cells by Co-culture of peripheral blood lymphocytes and tumor organoids, Cell, 174, 10.1016/j.cell.2018.07.009 Fumagalli, 2020, Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection, J. Exp. Med., 217, 10.1084/jem.20200298 Gehring, 2022, Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection, J. Hepatol., 77, 525, 10.1016/j.jhep.2022.02.020 Glanville, 2017, Identifying specificity groups in the T cell receptor repertoire, Nature, 547, 94, 10.1038/nature22976 Gong, 2021, Age-related changes in the TRB and IGH repertoires in healthy adult males and females, Immunol. Lett., 240, 71, 10.1016/j.imlet.2021.10.002 Höhn, 2002, Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen, Clin. Exp. Immunol., 129, 309, 10.1046/j.1365-2249.2002.01841.x Hoogeveen, 2019, Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection, Gut, 68, 893, 10.1136/gutjnl-2018-316644 Huang, 2020, Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening, Nat. Biotechnol., 38, 1194, 10.1038/s41587-020-0505-4 Lanfermeijer, 2020, How age and infection history shape the antigen-specific CD8(+) T-cell repertoire: implications for vaccination strategies in older adults, Aging Cell, 19, 10.1111/acel.13262 Le Bert, 2020, Effects of hepatitis B surface antigen on virus-specific and global T cells in patients with chronic hepatitis B virus infection, Gastroenterology, 159, 652, 10.1053/j.gastro.2020.04.019 Lian, 2020, Distinct T-cell receptor profiles associated with hepatitis B e antigen seroconversion during entecavir treatment, Liver Int., 40, 2672, 10.1111/liv.14566 Liang, 2009, Hepatitis B: the virus and disease, Hepatology, 49, S13, 10.1002/hep.22881 McMahon, 2009, The natural history of chronic hepatitis B virus infection, Hepatology, 49, S45, 10.1002/hep.22898 Rivino, 2018, Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation, J. Clin. Invest., 128, 668, 10.1172/JCI92812 Schuch, 2019, Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load, Gut, 68, 905, 10.1136/gutjnl-2018-316641 Webster, 2004, Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy, J. Virol., 78, 5707, 10.1128/JVI.78.11.5707-5719.2004 Wolfl, 2007, Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8(+) T cells responding to antigen without requiring knowledge of epitope specificities, Blood, 110, 201, 10.1182/blood-2006-11-056168 Xu, 2017, Dynamic perturbations of CD4 and CD8 T cell receptor repertoires in chronic hepatitis B patients upon oral antiviral therapy, Front. Immunol., 8, 1142, 10.3389/fimmu.2017.01142 Zandvliet, 2011, Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation, J. Immunother., 34, 307, 10.1097/CJI.0b013e318213cb90